2023
DOI: 10.1080/10942912.2023.2246678
|View full text |Cite
|
Sign up to set email alerts
|

Chrysin a promising anticancer agent: recent perspectives

Muhammad Shahbaz,
Hammad Naeem,
Muhammad Imran
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(3 citation statements)
references
References 119 publications
0
3
0
Order By: Relevance
“…3 h). Pharmacological degradation of HIF1α by Chrysin 39 , 40 also led to the accumulation of LC3B-II and p62 in Daoy and UW228 cells (Fig. 3 i).…”
Section: Resultsmentioning
confidence: 87%
“…3 h). Pharmacological degradation of HIF1α by Chrysin 39 , 40 also led to the accumulation of LC3B-II and p62 in Daoy and UW228 cells (Fig. 3 i).…”
Section: Resultsmentioning
confidence: 87%
“…Over the years, it has garnered interest for its potential health benefits, including its potential anticancer properties. Chr has been shown to exert its anticancer effects through various mechanisms, such as inhibiting tumor cell proliferation, inducing apoptosis, inhibiting inflammation, and modulating certain enzyme activities and signaling pathways [2,3]. However, its effectiveness in cancer treatment is restricted due to its water-repelling characteristics, poor absorption, swift breakdown, and fast metabolism.…”
Section: Introductionmentioning
confidence: 99%
“…However, the search for therapeutic agents that can be used in treatment continues due to high side effects. In recent years, natural products like flavonoids have become interesting in cancer treatment because they are less toxic and, therefore, cause fewer side effects [3].…”
Section: Introductionmentioning
confidence: 99%